• About   |
  • Write For Us   |
  • Contact Us   |
  • हिंदी
Tuesday, February 7, 2023
  • Login
  • Register
No Result
View All Result
The Second Angle
Advertise
  • Infotainment
    • Sports
  • Entertainment
    • Lifestyle
      • Home & Decoration
  • People
    • Inspiring
  • Education
  • Travel
  • Finance
  • Healthcare
  • Technology
  • World
The Second Angle
  • Infotainment
  • Entertainment
  • People
  • Education
  • Travel
  • Finance
  • Healthcare
  • Technology
  • World
Advertisement
ADVERTISEMENT
Home News

Cough syrup deaths | After inspection, India stops Maiden Pharma unit from making drugs

TSA Desk by TSA Desk
October 13, 2022
in News
Reading Time: 3 mins read
A A
Share on FacebookShare on WhatsApp
Advertisement Advertisement Advertisement
ADVERTISEMENT


All manufacturing activity at Haryana-based pharmaceutical company has been stopped pending investigation

RelatedPosts

With Glazers possibly out, check some of United’s potential buyers

With Glazers possibly out, check some of United’s potential buyers

Bar Council of T.N. & Puducherry suspends 9 lawyers from practicing before any forum

All manufacturing activity at Haryana-based pharmaceutical company has been stopped pending investigation

The Central Drugs Standard Control Organisation (CDSCO) and Haryana State Drugs Controller have directed a stop to all manufacturing activity at Maiden Pharmaceuticals Limited in Sonepat on grounds of deficiencies found following local inspection of the company’s facilities, a senior Health Ministry official has confirmed.

The World Health Organization (WHO) had on September 29 informed India’s national drug regulator that it was providing technical assistance and advice to the Gambia, where children had died and where a contributing factor was suspected to be the use of medicines manufactured by Maiden Pharmaceuticals, which may have been contaminated with diethylene glycol or ethylene glycol.

The Health Ministry, on Wednesday, also constituted a four-member technical expert committee comprising Dr. Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines (Chair); Dr. Pragya D. Yadav, National Institute of Virology, Indian Council of Medical Research, Pune; Dr. Arti Bahl, Division of Epidemiology, National Centre for Disease Control, Delhi; and A. K. Pradhan of the CDSCO.

“The committee will, after examining and analysing adverse event reports, causal relationship and all related details shared by the WHO, suitably advise and recommend government regulatory authorities about the further course of action. The committee may co-opt any other technical expert as deemed necessary,’’ a Health Ministry official said.

India was also informed by the WHO that according to tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples had been found to contain diethylene glycol/ ethylene glycol. “The WHO has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one-to-one causal relation of death has not yet been provided by the WHO to the CDSCO, although the CDSCO has requested the WHO twice in this regard,’’ the Health Ministry maintained on Wednesday.

The Ministry added that after being alerted by the WHO, the CDSCO took the matter up immediately with the Haryana State Regulatory Authority, under whose jurisdiction Maiden Pharmaceutical Limited’s the drug manufacturing unit is located.

The CDSCO launched a detailed investigation, with local inspection of the manufacturing premises carried out on October 1, 3, 6 and 11, to ascertain the facts along with the Haryana State Drugs Controller.

From the CDSCO’s preliminary enquiry, it was established that Maiden Pharmaceuticals Limited is the manufacturer licensed by the State Drug Controller for the products under reference — ‘Promethazine Oral Solution BP’, ‘Kofexnalin Baby Cough Syrup’, ‘MaKoff Baby Cough Syrup’ and ‘MaGrip n Cold Syrup’ — and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to Gambia.

It is the usual practice that the importing country tests medicines on quality parameters and satisfies itself as to their quality before releasing them for usage. In the present case, it’s not clear if these medicines were tested in Gambia before their release.

All four drugs are manufactured only for export by Maiden Pharmaceuticals Limited, and are not licensed for manufacture and sale in India. In effect, none of them is sold domestically in India.

“The samples (controlled samples of the same batch manufactured by M/s. Maiden Pharmaceuticals Limited for all the four drugs in question) have been taken and sent for testing to Regional Drug Testing Lab, Chandigarh by CDSCO, the results of which are awaited,’’ the Health Ministry said.

ShareSendTweet
TSA Desk

TSA Desk

Related Posts

With Glazers possibly out, check some of United’s potential buyers
Sports

With Glazers possibly out, check some of United’s potential buyers

One of the biggest stories on sports pages at the end of 2022, The American Glazer family, who are the...

Read more
News

Bar Council of T.N. & Puducherry suspends 9 lawyers from practicing before any forum

Photograph used for representational purposes only The Bar Council of Tamil Nadu and Puducherry (BCTNP) on Tuesday notified the suspension...

Read more
News

Kerala government agrees to debate Vizhinjam port agitation and related violence in the Assembly

An injured police personnel being shifted to a hospital after a mob of agitators attacked Vizhinjam police station following the...

Read more
News

Decisive G20 not possible without support of members, says Amitabh Kant

India’s G-20 Sherpa Amitabh Kant speaks at the first G20 Sherpa meeting, in Udaipur, on December 4. | Photo Credit:...

Read more
News

CBI moves Delhi HC challenging statutory bail granted to DHFL’s Wadhawan brothers

Dewan Housing Finance Corporation Limited The CBI on Monday approached the Delhi High Court challenging the statutory bail granted to...

Read more
News

Andhra Pradesh: We are working towards making Chittoor a major industrial hub, says Collector

Chittoor District Collector M. Hari Narayanan speaking to The Hindu on Monday. | Photo Credit: BY ARRANGEMENT Chittoor district holds...

Read more
Load More
Next Post
How to Store Edible Cannabis Properly

4 ways to store hemp edibles properly

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Facebook Twitter Instagram Telegram

About

The Second Angle

A platform providing diverse views on various issues, providing an in-depth understanding of important developments happening around us. It offers you true journalism amidst the cacophony. Discover the latest news, opinions, analysis and a lot more here.

Important Links

  • About
  • Career
  • Write for us | The Second Angle
  • Support Us
  • Privacy Policy
  • Terms
  • Contact Us
  • Newsletter
  • हिंदी

Subscribe to Our Newsletter

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

© 2017-22. The Second Angle. All Rights Reserved. Developed and Maintenance by SquareBase.io

No Result
View All Result
  • Infotainment
    • Sports
  • Entertainment
    • Lifestyle
      • Home & Decoration
  • People
    • Inspiring
  • Education
  • Travel
  • Finance
  • Healthcare
  • Technology
  • World
  • Login
  • Sign Up

© 2017-22. The Second Angle. All Rights Reserved. Developed and Maintenance by SquareBase.io

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Go to mobile version